FDA revokes authorization for last remaining monoclonal antibody treatment

FDA revokes authorization for last remaining monoclonal antibody treatment

One of our tools to fight COVID is now no longer an option as the FDA has officially revoked its authorization for the last remaining monoclonal antibody treatment.